Bollard Group LLC Forma Therapeutics Holdings, Inc. Transaction History

Bollard Group LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 12, 2022	SELL	$5.1 - $10.0 $806,820 - $1.58 Million	-158,200 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$8.34 - $14.69 $1.32 Million - $2.32 Million	158,200 New	158,200 $1.47 Million

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Bollard Group LLC, based on Form 13F filings with the SEC.

Stay updated on Bollard Group LLC with notifications on news.